Publicaciones en colaboración con investigadores/as de Hospital Universitario La Paz (9)

2022

  1. Non-metastatic castration-resistant prostate cancer: management recommendations

    Actas Urologicas Espanolas, Vol. 46, Núm. 4, pp. 193-213

2020

  1. El impacto del COVID-19 en la residencia en urología en España: perspectivas y recomendaciones

    Archivos espanoles de urologia, Vol. 73, Núm. 5, pp. 471-478

  2. Incidence of upper tract urothelial carcinoma in Spain

    Actas Urologicas Espanolas, Vol. 44, Núm. 7, pp. 512-518

2018

  1. Cognitive function in patients on androgen suppression: A prospective, multicentric study

    Actas Urologicas Espanolas, Vol. 42, Núm. 2, pp. 114-120

2017

  1. Cognitive Function in Patients With Prostate Cancer Receiving Luteinizing Hormone-Releasing Hormone Analogues: A Prospective, Observational, Multicenter Study

    International Journal of Radiation Oncology Biology Physics, Vol. 98, Núm. 3, pp. 590-594

2016

  1. Everolimus safety and efficacy for renal angiomyolipomas associated with tuberous sclerosis complex: A Spanish expanded access trial

    Orphanet Journal of Rare Diseases, Vol. 11, Núm. 1

2015

  1. The metabolic syndrome and its components in patients with prostate cancer on androgen deprivation therapy

    Journal of Urology, Vol. 193, Núm. 6, pp. 1963-1969

2013

  1. Biochemical markers of bone turnover and clinical outcome in patients with renal cell and bladder carcinoma with bone metastases following treatment with zoledronic acid: The TUGAMO study

    British Journal of Cancer, Vol. 109, Núm. 1, pp. 121-130

  2. Usefulness of bone turnover markers as predictors of mortality risk, disease progression and skeletal-related events appearance in patients with prostate cancer with bone metastases following treatment with zoledronic acid: TUGAMO study

    British Journal of Cancer, Vol. 108, Núm. 12, pp. 2565-2572